With a lot of studies pointing towards ‘gender diversity reaps better financial results for a company’, organizations have increasingly become more sensitive to making diversity and inclusion (D&I) a part of their strategic priorities. As per a global report by Grant Thornton, ‘India ranks third lowest in having women in leadership roles’. However, with the latest SEBI guidelines on board representation, these figures are slowly changing. As per a McKinsey & Company report, ‘Achieving gender equality in India would have a larger economic impact there than in any other region in the world.’ Some studies also reveal that the highest percentage of women executive directors in the pharmaceutical industry is only 7.69%. Organizations are now channelizing their efforts towards building a gender rich workforce, with a special focus on women in leadership roles. This panel discussion will be addressed by highly accomplished women from the pharma, biopharma and healthcare industry who are at leadership positions and have broken the glass ceiling in a previously male preserve. Key points of discussion:
- Understanding and addressing the reasons for the ‘leaky pipeline’
- Women as agents of change in ensuring a level playing field for peers
- Crafting an effective D&I organizational strategy
- Fostering a culture of learning, grooming and mentoring
- Strategies for self-promotion
- Reinventing leadership for the 21st century